CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis

被引：0
|
作者：
Minghuan Jiang
Joyce H. S. You
机构：
[1] The Chinese University of Hong Kong,School of Pharmacy, Faculty of Medicine
来源：
Cardiovascular Drugs and Therapy | 2017年 / 31卷
关键词：
Clopidogrel; Prasugrel; Ticagrelor; genotype; Acute coronary syndrome; Cost-effectiveness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：39 / 49
页数：10
相关论文
共 50 条
  • [41] Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations
    Kaavya Narasimhalu
    Yoong Kwei Ang
    Doreen Su Yin Tan
    Deidre Anne De Silva
    Kelvin Bryan Tan
    Clinical Drug Investigation, 2020, 40 : 1063 - 1070
  • [42] COST-EFFECTIVENESS OF A CYP2C19 GENOTYPE-GUIDED ANTIPLATELET STRATEGY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS: AN ANALYSIS BASED ON THE RANDOMIZED POPULAR GENETICS TRIAL
    Claassens, D.
    Vos, G. J. A.
    Boersma, C.
    Bergmeijer, T. O.
    Hermanides, R. S.
    van t Hof, A. W.
    Van der Harst, P.
    Barbato, E.
    Morisco, C.
    Gin, Tjon Joe R. M.
    Asselbergs, F. W.
    Mosterd, A.
    Herrman, J. P. R.
    Dewilde, W. J.
    Postma, M.
    Deneer, V. H. M.
    Ten Berg, J. M.
    VALUE IN HEALTH, 2020, 23 : S494 - S494
  • [43] Necessity of screening patients with stenting for acute coronary syndrome by CYP2C19 polymorphism
    Terentiev, I. T.
    Varlamova, M. A.
    Pavlova, N., I
    Dyakonova, A. T.
    Solov'eva, N. A.
    Kononova, S. K.
    Kurtanov, Kh A.
    YAKUT MEDICAL JOURNAL, 2018, (04): : 102 - 105
  • [44] CYP2C19 activity and cardiovascular risk factors in patients with an acute coronary syndrome
    Martinez-Quintana, Efren
    Rodriguez-Gonzalez, Fayna
    Maria Medina-Gil, Jose
    Garay-Sanchez, Paloma
    Tugores, Antonio
    MEDICINA CLINICA, 2017, 149 (06): : 235 - 239
  • [45] The effect of CYP2C19 genotype-guided antiplatelet therapy on outcomes of selective percutaneous coronary intervention patients: an observational study
    Tan, Kai
    Lian, Zhexun
    Shi, Yan
    Wang, Xiaxia
    Yu, Haichu
    Li, Mengwan
    Tian, Jianhui
    Ge, Yiping
    PERSONALIZED MEDICINE, 2019, 16 (04) : 301 - 312
  • [46] CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
    Beitelshees, Amber L.
    Thomas, Cameron D.
    Empey, Philip E.
    Stouffer, George A.
    Angiolillo, Dominick J.
    Franchi, Francesco
    Tuteja, Sony
    Limdi, Nita A.
    Lee, James C.
    Duarte, Julio D.
    Kreutz, Rolf P.
    Skaar, Todd C.
    Coons, James C.
    Giri, Jay
    McDonough, Caitrin W.
    Rowland, Rachel
    Stevenson, James M.
    Thai, Thuy
    Vesely, Mark R.
    Wellen, Jacob T.
    Johnson, Julie A.
    Winterstein, Almut G.
    Cavallari, Larisa H.
    Lee, Craig R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (04):
  • [47] Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients
    Huxley, Samuel
    Moriarty, James
    Hlatky, Mark A.
    Lennon, Ryan
    Bailey, Kent
    Bell, Malcolm
    Geller, Nancy
    Lerman, Amir
    Mathew, Verghese
    Rosenberg, Yves
    Farkouh, Michael
    Rihal, Charanjit
    Borah, Bijan
    Pereira, Naveen L.
    PHARMACOGENOMICS JOURNAL, 2024, 24 (06):
  • [48] Feasibility and implementation of CYP2C19 genotyping in patients using antiplatelet therapy
    Bergmeijer, Thomas O.
    Vos, Gerrit J. A.
    Claassens, Daniel M. F.
    Janssen, Paul W. A.
    Harms, Remko
    van der Heide, Richard
    Asselbergs, Folkert W.
    ten Berg, Jurrien M.
    Deneer, Vera H. M.
    PHARMACOGENOMICS, 2018, 19 (07) : 621 - 628
  • [49] RESEARCH CYP2C19*2 GENE POLYMORPHISM WITH ACUTE CORONARY SYNDROME
    Wangjiawang, Liufan
    Cuiwei, Xieruiqin
    Yangxiuchun, Lujingchao
    Peiweina, Liufan
    HEART, 2012, 98 : E60 - E61
  • [50] Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome
    Ozawa, Takuya
    Suda, Masayoshi
    Ikegami, Ryutaro
    Takano, Toshiki
    Wakasugi, Takayuki
    Yanagawa, Takao
    Tanaka, Komei
    Ozaki, Kazuyuki
    Hirono, Satoru
    Minamino, Tohru
    INTERNATIONAL HEART JOURNAL, 2018, 59 (01) : 21 - 26
12345